Invention Grant
- Patent Title: Macrocyclic hepatitis C serine protease inhibitors
- Patent Title (中): 大环丙型肝炎丝氨酸蛋白酶抑制剂
-
Application No.: US12584716Application Date: 2009-09-10
-
Publication No.: US08420596B2Publication Date: 2013-04-16
- Inventor: Yiyin Ku , Keith F. McDaniel , Hui-Ju Chen , Jason P. Shanley , Dale J. Kempf , David J. Grampovnik
- Applicant: Yiyin Ku , Keith F. McDaniel , Hui-Ju Chen , Jason P. Shanley , Dale J. Kempf , David J. Grampovnik
- Applicant Address: US IL Abbott Park US MA Watertown
- Assignee: Abbott Laboratories,Enanta Pharmaceuticals, Inc.
- Current Assignee: Abbott Laboratories,Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US IL Abbott Park US MA Watertown
- Agency: Edwards Wildman Palmer LLP
- Agent Jeffrey D. Hsi; Mark D. Russett
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
Public/Granted literature
- US20100144608A1 Macrocyclic hepatitis C serine protease inhibitors Public/Granted day:2010-06-10
Information query
IPC分类:
